Innovation
11 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 611 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Develops drug products for lung-related conditions
11 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 611 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |